Joint Approach

In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with  Michael Henry, MD and Daisuke Furukawa, MD on the topic of Suppressive Antibiotic Therapy (SAT) at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Michael Henry, MD and Daisuke Furukawa, MD in part 1 of this 2-part conversation on the topic of Suppressive Antibiotic Therapy at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]    

In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Here are the ICM links: DOCUMENTS | ICMORTHO. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD in part 1 of this 2-part conversation on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]    

In the final episode of this 2-part series, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation on Shoulder PJI definition evolution with Surena Namdari, MD, and Jason Hsu, MD. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com.

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they chat with Surena Namdari, MD, and Jason Hsu, MD in part 1 of this 2-part conversation on Shoulder PJI definition evolution. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit  bioMérieux.com. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected].

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Meredith Schade, MD, and Stephanie Hawkins, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In the conclusion of this series on long-acting antibiotics, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they wrap up the conversation with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproachor Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]   

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they continue the in-depth discussion on long-lasting antibiotics with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the second episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode.For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they have an in-depth discussion about long-lasting antibiotics with Vance Fowler, MD, MHS, Thomas Holland, MD,  and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]    

In this follow-up conversation from the International Consensus Meeting on Infection, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Allison Lastinger, MD, FACP, and Ran Schwarzkopf, MD about the question: “How can we capture the physical and psychological impact of orthopedic infections on patients?” FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the discussion on spinal implant infections with Geno Tai, MD, and Francis Lovecchio, MD. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]    

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss spinal implant infections with Gino Tai, MD, and Francis Lovecchio, MD in part 1 of this 2 part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]    

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Angela Hewlett, MD, and Curtis Hartman, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Host Jessica Seidelman, MD and guests Kerry LaPlante, Pharm.D., FCCP, FIDSA, FIDP, and Julie Ann Justo, Pharm.D. conclude this 3-part series with discussions on pipeline innovations and adjunctive strategies for treating challenging prosthetic joint infections. Topics include local antibiotic administration, phage therapy, and immunotherapy. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com Listen to Breakpoints: The SIDP Podcast References: “Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection” PMID 34042388 “NDM-9 resistance to taniborbactam” PMID 36796395 “Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern” PMID 37394537 IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections https://www.idsociety.org/practice-guideline/amr-guidance/ “Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety” PMID 30648126 “Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin” PMID 36985124 “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization” PMID 35510938 “Local antibiotic delivery via intra-articular catheter infusion for the treatment of periprosthetic joint infection: a systematic review” PMID 38691147 “A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model” PMID 26833157

Host Jessica Seidelman, MD and guests Kerry LaPlante, Pharm.D., FCCP, FIDSA, FIDP, and Julie Ann Justo, Pharm.D. continue discussing long-acting antibiotics, systemic vs. oral antibiotics, and drug and dosing perspectives in episode 2 of this 3-part conversation. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at BONESUPPORT.com Listen to Breakpoints: The SIDP Podcast References: “Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection” PMID 34042388 “NDM-9 resistance to taniborbactam” PMID 36796395  “Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern” PMID 37394537 IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections https://www.idsociety.org/practice-guideline/amr-guidance/ “Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety” PMID 30648126 “Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin” PMID 36985124 “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization” PMID 35510938 “Local antibiotic delivery via intra-articular catheter infusion for the treatment of periprosthetic joint infection: a systematic review” PMID 38691147 “A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model” PMID 26833157 FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]  

Host Jessica Seidelman, MD has an in-depth discussion with Kerry LaPlante, Pharm.D., FCCP, FIDSA, FIDP, and Julie Ann Justo, Pharm.D. in the opening episode of this 3-part series. They discuss why PJI infections are so difficult to treat, and advances in antimicrobial agents in the pipeline. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at BONESUPPORT.com Listen to Breakpoints: The SIDP Podcast References: “Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection” PMID 34042388 “NDM-9 resistance to taniborbactam” PMID 36796395 “Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern” PMID 37394537 IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections “Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety” PMID 30648126 “Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin” PMID 36985124 “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated with Dalbavancin: Case Report and Isolate Characterization” PMID 35510938 “Local antibiotic delivery via intra-articular catheter infusion for the treatment of periprosthetic joint infection: a systematic review” PMID 38691147 “A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model” PMID 26833157 FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]  

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss another challenging case with Jenny Aronson, MD.  Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a the first of two challenging cases with Jenny Aronson, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Jessica Seidelman, MD, and Johannes Plate, MD. PhD conclude this discussion on the role of the Megaprosthesis in oncological indications with Juan Pretell, MD and Santiago Lozano-Calderon, MD, PhD. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Jessica Seidelman, MD, and Johannes Plate, MD, PhD host Juan Pretell, MD and Santiago Lozano-Calderon, MD, PhD as they discuss the role of the Megaprosthesis in oncological indications. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including results from the APEX clinical trials, please visit Ostealtx.com FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Alaina Ritter, MD, and Minu Abraham, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]  

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Jakrapun Pupaibool, MD, MS. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they conclude the discussion, Patient Perspectives of PJI with William Jiranek, MD, and  James Campbell, who is a registered nurse, a vascular access specialist, and a prosthetic joint infection survivor. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss Patient Perspectives of PJI with William Jiranek, MD, and  James Campbell, who is a registered nurse, a vascular access specialist, and a prosthetic joint infection survivor. Stay tuned for the conclusion of this series. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this new Case Study Series entitled Bugged and Baffled.  In this episode, they discuss a challenging case with Andy Miller, MD, Current President of MSIS, and Chief of Infectious Diseases at HSS. Spoiler alert- this case has just been published in JBJS and can be found at this link to the article.  Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude this discussion onBiofilm with Ken Urish, MD, and Alexander Tatara, MD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they have an engaging discussion on Biofilm with Ken Urish, MD, and Alexander Tatara, MD in part 1 of this 2 part series.  Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude this discussion on shoulder periprosthetic joint infections with Mark Cullen, MD, Bryan Crook, MD and Christopher Klifto, MD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]  

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss shoulder periprosthetic joint infections with Mark Cullen, MD, Bryan Crook, MD and Christopher Klifto, MD in part 1 of this 2 part series. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude this discussion on diabetic foot infections with Kyle Wamelink, DPM and Marcos Schecter, MD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss diabetic foot infections with Kyle Wamelink, DPM and Marcos Schecter, MD in part 1 of this 2 part series. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they discuss dental prophylaxis with Elie Berbari, MD, MBA and Charles Hannon, MD, MBA.    FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they conclude the conversation with Alaina Ritter, MD, and Malcolm DeBaun, MD about Fracture Related Infections. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they talk with Alaina Ritter, MD, and Malcolm DeBaun, MD in Part 1 of this discussion on Fracture Related Infections. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here    FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]  

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they conclude the conversation with Professor Fares Haddad, MBBS MD, MCh, FRCS FFSEMMD, and Thomas Fehring, MD about one-stage vs. two-stage revision with PJI. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they talk with Professor Fares Haddad, MBBS MD, MCh, FRCS FFSEMMD, and Thomas Fehring, MD about one-stage vs. two-stage revision to treat PJI.   Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here .  FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Francesco Petri, MD chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD.  FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]  

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Jaclyn Jankowski, DO chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here.

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Gerhard Maale, MD chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD. FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Marjorie Golden, MD chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Antonia Chen, MD chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD. Thanks to Irrisept for sponsoring this episode. For more information about Irrisept products, please click here.

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Carl Deirmengian, MD chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD.  FOLLOW us on X  @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Carlos Higuera, MD chats with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD.  FOLLOW us on X (formerly twitter) @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In this episode from the Musculoskeletal Infection Society 34th Annual Open Scientific Meeting, Ken Urish, MD, PhD chats about his research with hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please visit Biocomposites.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they conclude the discussion with Marjan Wouthuyzen-Bakker, MD, and Nicolas Cortes-Penfield MD on oral antibiotics to treat bone and joint infections. FOLLOW us on X (formerly twitter) @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they talk with Marjan Wouthuyzen-Bakker, MD, and Nicolas Cortes-Penfield MD about using Oral Antibiotics to treat bone and joint infections. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at bonesupport.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In the conclusion of this series, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD finish the discussion with Ken Urish, MD, PhD and Gina Suh, MD about Bacteria Phages and their use in treating bone and joint infections. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at BONESUPPORT.com FOLLOW us on X (formerly twitter) @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they talk with Ken Urish, MD, PhD and Gina Suh, MD about Bacteria Phages and their use in treating bone and joint infections in this two part series. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at bonesupport.com FOLLOW us on X (formerly twitter) @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]

In this final episode of the Surgical Site Infection Prevention series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude their discussion with Tobias Kramer, PD Dr. med, MSc and Keith Kaye, MD, MPH. This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G with Gentamicin. CERAMENT G is an FDA-designated breakthrough device offering proven bone remodeling with reliable elution of broad-spectrum Gentamicin. CERAMENT G has a 96% success rate in eradication of infection in a single-stage for patients with fracture related infections and chronic osteomyelitis. To learn more and review CERAMENT G cases, visit their website at bonesupport.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at [email protected]